DALLAS, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more ...
Spectral AI's DeepView System excels over physicians in identifying non-healing burn tissue, aiming for FDA clearance by mid-2025. Spectral AI has announced positive results from its Burn Validation ...
Image source: The Motley Fool. Spectral AI (NASDAQ:MDAI) advanced its DeepView commercialization strategy with regulatory and financial milestones, including a timely FDA de novo submission and ...
Multispectral Imaging and Assessment of Burns Healing Potential: A Prospective Real-World Study to assess the DeepView Snapshot Imaging Platform – Sam Snelling, North Bristol NHS Trust, Bristol, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results